Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-04

Clinical Trial Update: Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nimotuzumab in combination with concurrent chemoradiotherapy for locally advanced esophageal cancer in older adults has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimotuzumab (nimotuzumab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Esophageal Carcinoma | Phase 2 | Status: COMPLETED